Drug Profile
E 4701
Latest Information Update: 21 May 2001
Price :
$50
*
At a glance
- Originator Eisai Co Ltd
- Class Ischaemic heart disorder therapies; Organic nitrates; Vasodilators
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Ischaemic heart disorders
Most Recent Events
- 21 May 2001 Discontinued-Preclinical for Heart failure in Japan (Unknown route)
- 21 May 2001 Discontinued-Preclinical for Ischaemic heart disorders in Japan (Unknown route)
- 21 Aug 1998 No-Development-Reported for Heart failure in Japan (Unknown route)